Rapport Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $22.06-$52.93 |
Market Cap | $1.4B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $20M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$21.8M |
Diluted EPS | -$3.03 |
News
See moreYahoo Finance • 15 days ago
Can This Small Biotech Enter A $4.3 Billion AbbVie Market? Rapport Shoots Higher
Yahoo Finance • last month
4 Biotech Stocks With Key Clinical Readouts Expected This Fall
Yahoo Finance • 2 months ago
Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch.
Yahoo Finance • 3 months ago
Rapport Therapeutics reports Q2 results
About
CEO | Mr. Abraham N. Ceesay M.B.A. |
Address | 99 High Street, Boston, MA, United States, 02110 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 84 |